TickerSparkInvestor Intelligence
TickerSparkInvestor Intelligence
Community
Main Feed
Today's Market Intel
Top Stocks
AI-Curated Stock Lists
IPO Calendar
Upcoming Listings
Stock Teasers
The Stock Behind the Promo
Trending Stocks
Today's Big Movers
Earnings Coverage
Flashes & Deep Dives
Macro Updates
Economy & Markets
Stock Reports
AI Research Reports
Commentary
Opinionated Stock Takes
Custom Reports
Stock Deep Dives · Free to Try
AI Analyst
Agentic Chat · Free to Try
Watchlist
Track Your Stocks · Free
Spark Charts
AI Technical Analysis · Free to Try
Intel Dashboard
Daily Trade Ideas
Trade Tracker
AI-Managed Portfolio · Pro
My Portfolio
Brokerage Connected · Pro
Custom Reports
Stock Deep Dives
AI Analyst
Agentic Chat
Watchlist
Your Stocks & Notes
Spark Charts
AI Technical Analysis
Intel Dashboard
Daily Trade Ideas
Trade Tracker
AI-Managed Portfolio
My Portfolio
Brokerage Connected
Account
Plan, Billing & Appearance
Log inCreate Account
← Back to TickerSpark
▌Earnings Flash·August 26, 2026

Phibro Animal Health Corporation (PAHC) rises on earnings beats

Phibro Animal Health Corporation (PAHC) rises 6.2% after posting earnings beats, lifting shares as investors react to stronger-than-expected quarterly results.

Earnings FlashPAHCHealthcareDrug Manufacturers - Specialty & Generic
By TickerSpark·August 26, 2026·2 min read
Phibro Animal Health Corporation (PAHC) rises on earnings beats
▌Key Takeaway
Phibro Animal Health Corporation (NASDAQ: PAHC) beat both EPS and revenue, reporting $0.85 per share on $0.40 billion in sales versus estimates of $0.713 and $0.38 billion. Shares jumped 6.18% to $38.15 in after-hours trading, signaling a positive near-term investor reaction to the double beat. The result extends PAHC’s five-quarter streak of EPS beats, but investors will want management to show that the improvement is durable and not just a low-bar quarter.

Phibro Animal Health Corporation (PAHC) rises after earnings beat

Phibro Animal Health Corporation (PAHC) beat on EPS and revenue, reporting $0.85 and $0.40B versus estimates of $0.713 and $0.38B, while shares rose 6.18% to $38.15 in after-hours trading.

Key Numbers

  • EPS: $0.85 actual versus $0.713 estimated, marking a beat.

§ Product

  • How It Works
  • Custom Reports
  • AI Analyst
  • Intel Dashboard
  • Spark Charts
  • Trade Tracker
  • My Portfolio
  • Plans

§ Research

  • Main Feed
  • Community
  • Stock Reports
  • Macro Updates
  • Blog

§ Company

  • About Us
  • Contact

§ Fine Print

  • Terms of Service
  • Privacy Policy
  • Full Disclaimer
  • Cookie Policy

Notice: All content and data on TickerSpark is for informational purposes only and does not constitute financial or investment advice. All investments involve risk. Please see our Full Disclaimer for more details.

© 2026 Maxwell Cyberlogic LLC

Not Investment Advice

Made in Delaware, USA

Revenue: $0.40B actual versus $0.38B estimated, also a beat.
  • After-hours reaction: PAHC rose 6.18% to $38.15, compared with a $35.93 regular-session close.
  • Earnings consistency: PAHC has beaten EPS estimates in each of the five quarters listed.

    • A Double Beat Extends PAHC's Earnings Momentum

    The double beat gives PAHC a stronger near-term signal than an EPS-only surprise. Revenue also cleared its estimate, so the upside reached both headline lines. The 6.18% after-hours gain shows an immediate positive market response, although the move comes from extended-hours trading rather than a regular-session close.

    On the earnings call, investors should focus on the operating drivers behind the $0.85 EPS and $0.40B revenue. Management's explanation can help separate durable improvement from a quarter in which estimates were simply too low. A repeatable result would matter more than the headline beat because PAHC has exceeded EPS estimates in each of the five quarters listed.

    That run gives PAHC a credible earnings-momentum angle, but the path has been uneven. EPS moved from $0.57 in August 2025 to $0.73 in November, reached $0.87 in February, slipped to $0.76 in May, and returned to $0.85 in August. The latest result remains below February's high, but it exceeds the prior two quarters. The pattern supports consistency against estimates, not a straight-line growth claim.

    Get AI research on any stock

    Instant reports, daily intelligence, and an AI analyst in your pocket.

    Get Started →

    Bottom Line

    PAHC delivered a double beat and a 6.18% after-hours rise, extending a five-quarter EPS beat streak that now needs repeatable operating support.

    Read the full PAHC research report
    ▌Common Questions

    Frequently asked questions

    +Why did Phibro Animal Health stock rise after earnings?
    Phibro Animal Health Corporation (PAHC) rose because it beat both earnings and revenue expectations, posting $0.85 EPS versus $0.713 estimated and $0.40 billion in revenue versus $0.38 billion expected. The stock gained 6.18% to $38.15 in after-hours trading after closing the regular session at $35.93.
    +Did Phibro Animal Health beat on both EPS and revenue?
    Yes, PAHC delivered a double beat. It reported $0.85 in EPS against an estimate of $0.713 and revenue of $0.40 billion versus the $0.38 billion consensus.
    +How much did PAHC stock move after the earnings report?
    PAHC shares rose 6.18% in after-hours trading to $38.15. That move came after the stock finished the regular session at $35.93.
    +Is Phibro Animal Health showing consistent earnings beats?
    Yes, the article says PAHC has beaten EPS estimates in each of the five quarters listed. The latest quarter continued that streak, although the company still needs repeatable operating improvement to prove the gains are durable.
    ▌The Daily Briefing · Free

    A new stock idea, every evening.

    One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.

    Daily market recap + weekly preview. One-click unsubscribe in every email.

    ▌The Full Report

    Want the full picture on PAHC?

    The analyst-grade research report — charts, grades, valuation, and price targets — in 10 minutes.

    Read the PAHC report →Get Full Access →

    Not ready to subscribe? ·

    ▌The Full Report

    Get the full PAHC research report

    • Analyst-grade deep dive
    • Charts, valuation, grades
    • Buy/sell price targets
    Read the PAHC report →
    ▌For Active Investors

    Smarter research, on every ticker

    • Daily market intelligence
    • On-demand stock analysis
    • AI analyst chat
    Get Full Access →

    Cancel anytime

    ▌The Daily Briefing · Free

    A new stock idea, every evening.

    One stock worth watching each weekday, free in your inbox.

    Daily market recap + weekly preview. One-click unsubscribe in every email.

    ▌More on PAHC

    More to read

    All articles
    Phibro Animal Health Corporation (PAHC) gains on deep earnings
    PAHC

    Phibro Animal Health Corporation (PAHC) gains on deep earnings

    Phibro Animal Health Corporation (PAHC) gained after a strong earnings beat, but the bigger story is the depth behind it: profit growth outpaced revenue, Animal Health led segment momentum, and management raised fiscal 2026 and 2027 guidance above consensus, reinforcing the bullish setup.

    Aug 27·7 min
    Phibro Animal Health (PAHC): Growth vs. Leverage Risk
    PAHC

    Phibro Animal Health (PAHC): Growth vs. Leverage Risk

    Phibro Animal Health is executing well after the Zoetis portfolio acquisition, with double-digit sales and EBITDA growth. But elevated leverage and regulatory exposure keep the stock in Hold territory.

    Aug 26·22 min
    The Ensign Group (ENSG): Growth, Quality, and Premium Valuation
    ENSG

    The Ensign Group (ENSG): Growth, Quality, and Premium Valuation

    Ensign combines strong revenue and EPS growth with improving clinical outcomes and disciplined acquisitions. The stock looks attractive operationally, but its premium valuation and reimbursement mix keep the upside tied to continued execution.

    Sep 7·18 min